ScholarGate
Assistent

Compara mètodes

Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.

Farmacovigilància PRR/ROR×Assaig de permeabilitat de cèl·lules Caco-2×
CampFarmacologiaFarmacologia
FamíliaProcess / pipelineProcess / pipeline
Any d'origen20021989
Autor originalArne Melander and colleaguesIngrid Hidalgo
Tipussafety signal detectionabsorption screening
Font seminalSzarfman, A., Tonning, J. M., Doraiswamy, P. M., & Osgood, D. J. (2002). Pharmacovigilance in the post-marketing setting: establishing causal links between drugs and adverse events. Drug Safety, 25(9), 619-631. link ↗Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736-749. DOI ↗
ÀliesPRR, ROR, signal detection, adverse event monitoringCaco-2 assay, intestinal permeability, ADME screening
Relacionats33
ResumProportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) are statistical methods for detecting safety signals in spontaneous adverse event reporting databases. Developed and formalized by researchers in the early 2000s, these measures identify drug-adverse event associations that warrant further investigation.The Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and identification of transporter-mediated transport.
ScholarGateConjunt de dades
  1. v1
  2. 2 Fonts
  3. PUBLISHED
  1. v1
  2. 2 Fonts
  3. PUBLISHED

Ves a la cerca Baixa les diapositives

ScholarGateCompara mètodes: Pharmacovigilance PRR/ROR · Caco-2 Permeability. Recuperat el 2026-06-18 de https://scholargate.app/ca/compare